KMB
40
-4
EL
33
3
LB
52
7
HRL
36
-2
BXP
63
-4
CRM
55
-4
USB
42
2
HBAN
45
-2
EQR
57
-2
AVGO
40
-24
NWSA
47
4
DAL
64
6
DFS
56
2
EQIX
60
-3
WFC
58
3
FE
50
-7
NOV
45
3
SYF
65
7
ECL
72
-2
GOOG
61
2
KMB
40
-4
EL
33
3
LB
52
7
HRL
36
-2
BXP
63
-4
CRM
55
-4
USB
42
2
HBAN
45
-2
EQR
57
-2
AVGO
40
-24
NWSA
47
4
DAL
64
6
DFS
56
2
EQIX
60
-3
WFC
58
3
FE
50
-7
NOV
45
3
SYF
65
7
ECL
72
-2
GOOG
61
2
Financhill
Back

AIM ImmunoTech Quote, Financials, Valuation and Earnings

Free 23-page book shares my #1 indicator to use

Here's the 23-page free book.
Sell
23

AIM
AIM ImmunoTech

Last Price:
0.31
Seasonality Move:
-12.56%

7 Day Trial

ALL ACCESS PASS

$ 7

"EarnPhone": The Investment Hidden in Plain Sight

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

AIM ImmunoTech Price Quote

$0.31
0.00 (-0.32%)
(Updated: September 18, 2024 at 6:55 PM ET)

AIM ImmunoTech Key Stats

Sell
23
AIM ImmunoTech (AIM) is a Sell
Day range:
$0.30 - $0.33
52-week range:
$0.25 - $0.62
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
77.29
P/B ratio:
2.91%
Volume:
346.7K
Avg. volume:
257.9K
1-year change:
-48.75%
Market cap:
$17.8M
Revenue:
$202K
EPS:
$-0.57

How Much Does AIM ImmunoTech Make?

Is AIM ImmunoTech Growing As A Company?

  • What Is AIM ImmunoTech's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.19%
  • What Is AIM ImmunoTech's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

AIM ImmunoTech Stock Price Performance

  • Did AIM ImmunoTech Stock Go Up Last Month?
    AIM ImmunoTech share price went up by 2.67% last month
  • Did AIM's Share Price Rise Over The Last Year?
    AIM share price fell by -48.75% over the past 1 year

What Is AIM ImmunoTech 52-Week High & Low?

AIM ImmunoTech Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy AIM ImmunoTech?

  • How Much Debt Does AIM ImmunoTech Have?
    Total long term debt quarterly is $2.6M
  • How Much Cash Does AIM ImmunoTech Have?
    Cash and short term investments quarterly total is $10.1M
  • What Is AIM ImmunoTech’s Book Value Per Share?
    Book value per share is 0.11

Is AIM ImmunoTech Cash Flow Positive?

  • What Is AIM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$23.3M
  • What Is AIM ImmunoTech’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $5.7M
  • What Is AIM ImmunoTech’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $118K

AIM ImmunoTech Return On Invested Capital

  • Is Management Doing A Good Job?
    AIM return on invested capital is -177.26%
  • What Is AIM ImmunoTech Return On Assets?
    ROA measures how assets are converting to revenues and is -124.35%
  • What Is AIM Return On Equity?
    ROE is a measure of profitability and is -189.75%

AIM ImmunoTech Earnings Date & Stock Price

AIM ImmunoTech Competitors

  • Who Are AIM ImmunoTech's Competitors?
    Below is a list of companies who compete with AIM ImmunoTech or are related in some way:
    • Armata Pharmaceuticals Inc (ARMP)
    • Perspective Therapeutics Inc (CATX)
    • Electromed Inc (ELMD)
    • Protalix BioTherapeutics Inc (PLX)
    • Xtant Medical Holdings Inc (XTNT)

AIM ImmunoTech Dividend Yield

AIM ImmunoTech Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 75.68%
Revenue: 19.05% 0%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 3.50
Upside from Last Price: 1025.4%

Major Shareholders

  • How many AIM shares are owned by institutional investors?
    10.5M AIM shares are owned by institutional investors
  • How many AIM shares are owned by insiders?
    4.7M AIM shares are owned by insiders